Arthur H Hayes Jr's Net Worth
$25.6 Million
Who is Arthur H Hayes Jr?
Arthur H Hayes Jr has an estimated net worth of $25.6 Million. This is based on reported shares across multiple companies, which include QUANTRX BIOMEDICAL CORP, CELGENE CORP /DE/, and MYRIAD GENETICS INC.
SEC CIK
Arthur H Hayes Jr's CIK is 0001191077
Past Insider Trading and Trends
2005 was Arthur H Hayes Jr's most active year for acquiring shares with 10 total transactions. Arthur H Hayes Jr's most active month to acquire stocks was the month of November. 2005 was Arthur H Hayes Jr's most active year for disposing of shares, totalling 8 transactions. Arthur H Hayes Jr's most active month to dispose stocks was the month of January. 2008 saw Arthur H Hayes Jr paying a total of $895,314.00 for 84,750 shares, this is the most they've acquired in one year. In 2006 Arthur H Hayes Jr cashed out on 460,000 shares for a total of $10,591,750.00, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
QUANTRX BIOMEDICAL CORP (QTXB) Snapshot price: $0.0001
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 31
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 31
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 31
| |||
| No matching records found | |||||||||
CELGENE CORP /DE/ No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
$33.46 | -$2,602,110.00 |
0
|
Feb 9
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 17
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 18
| |||
Form 4
|
—
|
0
|
$37.51 | -$2,710,080.00 |
0
|
May 13
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 17
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 17
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 17
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 12
| |||
Form 4
|
—
|
0
|
$35.47 | -$1,666,029.00 |
0
|
May 8
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 15
| |||
Form 4
|
—
|
0
|
$31.45 | -$2,765,712.00 |
0
|
Nov 14
| |||
Form 4
|
—
|
0
|
$25.99 | -$2,092,185.00 |
0
|
Aug 2
| |||
Form 4
|
—
|
0
|
$21.39 | -$4,819,776.00 |
0
|
Mar 27
| |||
Form 4
|
—
|
0
|
$31.04 | -$3,510,876.00 |
0
|
Dec 28
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 29
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 15
| |||
Form 4
|
—
|
0
|
$21.01 | -$1,480,680.00 |
0
|
May 18
| |||
Form 4
|
—
|
0
|
$17.67 | -$1,879,950.00 |
0
|
Mar 23
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 15
| |||
Form 4
|
—
|
0
|
$14.73 | -$1,297,780.00 |
0
|
Feb 2
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 15
| |||
Form 4
|
—
|
0
|
$30.94 | -$823,170.00 |
0
|
Sep 16
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 15
| |||
| No matching records found | |||||||||
MYRIAD GENETICS INC (MYGN) Snapshot price: $26.97
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Nov 12
| |||
| No matching records found | |||||||||